These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 6610537

  • 1. Resistance to trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia. Implication of folinic acid.
    Nunn PP, Allistone JC.
    Chest; 1984 Jul; 86(1):149-50. PubMed ID: 6610537
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Trimetrexate with leucovorin versus trimethoprim-sulfamethoxazole for moderate to severe episodes of Pneumocystis carinii pneumonia in patients with AIDS: a prospective, controlled multicenter investigation of the AIDS Clinical Trials Group Protocol 029/031.
    Sattler FR, Frame P, Davis R, Nichols L, Shelton B, Akil B, Baughman R, Hughlett C, Weiss W, Boylen CT.
    J Infect Dis; 1994 Jul; 170(1):165-72. PubMed ID: 8014493
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Failure of trimethoprim-sulfamethoxazole in the therapy of recurrent Pneumocystis carinii pneumonia.
    Mitsuyasu RT, Corwin HL, Harris AA, Trenholme GM, Levi S, Karkusis PH.
    Am Rev Respir Dis; 1982 Jun; 125(6):762-5. PubMed ID: 6979960
    [Abstract] [Full Text] [Related]

  • 7. Effect of folic and folinic acid on cytopenia occurring during co-trimoxazole treatment of Pneumocystis carinii pneumonia.
    Bygbjerg IC, Lund JT, Hørding M.
    Scand J Infect Dis; 1988 Jun; 20(6):685-6. PubMed ID: 3265540
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia.
    Ann Intern Med; 1987 Mar; 106(3):474-6. PubMed ID: 3492953
    [No Abstract] [Full Text] [Related]

  • 11. Atypical Pneumocystis carinii pneumonia: the potential hazards of empiric treatment.
    Peters JW, Sattler FR.
    South Med J; 1983 Jun; 76(6):800-3. PubMed ID: 6602384
    [Abstract] [Full Text] [Related]

  • 12. Successful treatment of Pneumocystis carinii pneumonia with trimethoprim-sulfamethoxazole in hypersensitive AIDS patients.
    Gibbons RB, Lindauer JA.
    JAMA; 1985 Mar 01; 253(9):1259-60. PubMed ID: 3871490
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of pentamidine isethionate and trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia.
    Hughes WT, Feldman S, Chaudhary SC, Ossi MJ, Cox F, Sanyal SK.
    J Pediatr; 1978 Feb 01; 92(2):285-91. PubMed ID: 304478
    [Abstract] [Full Text] [Related]

  • 14. Use of trimethoprim-sulfamethoxazole in pediatric infections: relative merits of intravenous administration.
    Overturf GD.
    Rev Infect Dis; 1987 Feb 01; 9 Suppl 2():S168-76. PubMed ID: 3554455
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of Pneumocystis carinii pneumonia (PCP) with trimethoprim-sulfamethoxazole and pentamidine in human immunodeficiency virus (HIV) infected patients--a case study and review of literature].
    Akamatsu E, Young C, Negishi M, Masuda G.
    Kansenshogaku Zasshi; 1988 Jun 01; 62(6):551-6. PubMed ID: 3138328
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.